This inventor holds 2 USPTO granted patents. Top assignees: Ono Pharmaceutical Co., Ltd., Vanderbilt University. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 575 
2 out of 1,220 
Years Active: 2021-2023
Title: Kevin M McGowan: Innovator in Kchannel Activation
Introduction
Kevin M McGowan is a notable inventor based in Nashville, TN, with a focus on the activation of TREK (TWIK Related Kchannels) channels. He holds two patents that contribute to advancements in this field. His work has implications for various medical and scientific applications.
Latest Patents
Among his latest patents is a compound of formula (I) that serves as an activator of TREK channels. This innovation is significant in understanding and manipulating Kchannel activity, which can have various therapeutic applications.
Career Highlights
Kevin has worked with prominent organizations such as Ono Pharmaceutical Co., Ltd. and Vanderbilt University. His experience in these institutions has allowed him to develop and refine his innovative ideas in the realm of biochemistry and pharmacology.
Collaborations
Throughout his career, Kevin has collaborated with esteemed colleagues, including Craig William Lindsley and Joshua M Wieting. These partnerships have fostered a collaborative environment that enhances the research and development of new technologies.
Conclusion
Kevin M McGowan is a distinguished inventor whose contributions to Kchannel activation are noteworthy. His patents and collaborations reflect his commitment to advancing scientific knowledge and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile